newsfilter
← Latest News
GlobeNewswire·

Ambrx Announces $75 Million Market Priced Registered Offering

SAN DIEGO, May 24, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the "Company") (NASDAQ:AMAM), today announced that it has entered into a securities purchase agreement with clients managed by Darwin